Amgen, Inc. (AMGN)
317.74
+0.36
(+0.11%)
USD |
NASDAQ |
Dec 12, 16:00
319.00
+1.26
(+0.40%)
After-Hours: 20:00
Amgen Research and Development Expense (Annual): 5.676B for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biogen, Inc. | 1.755B |
| Gilead Sciences, Inc. | 5.816B |
| Johnson & Johnson | 17.26B |
| Eli Lilly & Co. | 10.99B |
| Regeneron Pharmaceuticals, Inc. | 4.624B |